Evidence map›Paper›PMID 36958464›Full record

ReviewReproductive toxicology (Elmsford, N.Y.)2023

Maternal SSRI use during pregnancy and offspring depression or anxiety disorders: A review of the literature and description of a study protocol for a register-based cohort study.

Subina Upadhyaya, Alan Brown, Keely Cheslack-Postava, Mika Gissler, David Gyllenberg, Emmi Heinonen, Joonas Laitinen, Ian McKeague, Susanna Hinkka-Yli-Salomäki, Andre Sourander and 2 more

Open access · hybridAbstract readReview
In one paragraph

Review in Reproductive toxicology (Elmsford, N.Y.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Subina UpadhyayaResearch Centre for Child Psychiatry, Department of Child Psychiatry, University of Turku, INVEST Flagship Centre, Turku, Finland.
Alan BrownDepartment of Psychiatry, New York State Psychiatric Institute, Columbia University Irving Medical Center, New York, NY, USA; Department of Epidemiology, Columbia University, Mailman School of Public Health, New York, NY, USA.
Keely Cheslack-PostavaDepartment of Psychiatry, New York State Psychiatric Institute, Columbia University Irving Medical Center, New York, NY, USA.
Mika GisslerResearch Centre for Child Psychiatry, Department of Child Psychiatry, University of Turku, INVEST Flagship Centre, Turku, Finland; Finnish Institute for Health and Welfare, Helsinki, Finland.
David GyllenbergResearch Centre for Child Psychiatry, Department of Child Psychiatry, University of Turku, INVEST Flagship Centre, Turku, Finland.
Emmi HeinonenResearch Centre for Child Psychiatry, Department of Child Psychiatry, University of Turku, INVEST Flagship Centre, Turku, Finland.
Joonas LaitinenResearch Centre for Child Psychiatry, Department of Child Psychiatry, University of Turku, INVEST Flagship Centre, Turku, Finland.
Ian McKeagueColumbia University Mailman School of Public Health, Department of Biostatistics, New York, NY, USA.
Susanna Hinkka-Yli-SalomäkiResearch Centre for Child Psychiatry, Department of Child Psychiatry, University of Turku, INVEST Flagship Centre, Turku, Finland.
Andre SouranderResearch Centre for Child Psychiatry, Department of Child Psychiatry, University of Turku, INVEST Flagship Centre, Turku, Finland.
Aleksi TornioInstitute of Biomedicine, University of Turku and Unit of Clinical Pharmacology, Turku University Hospital, Turku, Finland.
Heli MalmResearch Centre for Child Psychiatry, Department of Child Psychiatry, University of Turku, INVEST Flagship Centre, Turku, Finland; Teratology Information, Helsinki University and Helsinki University Hospital, Department of Emergency Medicine Services, Helsinki, Finland; Department of Clinical Pharmacology, Helsinki University and Helsinki University Hospital, Helsinki, Finland; Individualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland. Electronic address: heli.malm@hus.fi.
University of Turku · FIColumbia University · USColumbia University Irving Medical Center · USUniversity of Helsinki · FI

Funding

Maternal exposure to antidepressants and psychiatric outcomes among offspring in a national birth cohort.R01MH118247 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI BROWN, ALAN STEWART · 2019 to 2022
$2.0M
NIMH NIH HHS R01 MH118247
6 · The paper itself

Abstract

Previous studies examining the relationship between in utero exposure to selective serotonin reuptake inhibitors (SSRI) and long-term offspring depressive or anxiety behaviors are inconclusive. We aimed to critically review the findings of previous studies and describe a new study protocol to investigate the association of prenatal SSRI exposure and offspring depression or anxiety using data from several Finnish national registers. The study includes 1,266,473 mothers and their live-born singleton offspring, born in 1996-2018. The study cohorts include the prenatally SSRI exposed group and three comparison groups: 1) depression exposed/antidepressants unexposed, 2) unexposed to antidepressants or antipsychotics and depression, and 3) discordant siblings. We aim to examine whether depression in prenatally SSRI exposed children is more common or severe than depression in the offspring of mothers with depression but without SSRI exposure. We aim to disambiguate the effects of maternal SSRI from the effects of maternal depression, severity of maternal depression and familial loading history of psychiatric disorders by including data from first-degree relatives of prenatally SSRI exposed and unexposed children. Associations between exposure and outcome are assessed by statistical modeling, accounting for within-family correlation. The study has potential public health significance and in guiding clinicians in considering treatment options for pregnant women.

Indexed as

Pregnancy ComplicationsPrenatal Exposure Delayed EffectsAdultAntidepressive AgentsAnxiety DisordersChildCohort StudiesDepressionFemaleHumansParturitionPregnancySelective Serotonin Reuptake InhibitorsAntidepressive AgentsSelective Serotonin Reuptake InhibitorsAnxietyDepressionMaternalOffspringPregnancySSRI

Identifiers

PMID36958464
PMCPMC11083215
OpenAlexW4353094156

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.